| Antidepressant drug effects and depression severity: a patient-level meta-analysis JC Fournier, RJ DeRubeis, SD Hollon, S Dimidjian, JD Amsterdam, ... Jama 303 (1), 47-53, 2010 | 2628 | 2010 |
| Cognitive therapy vs medications in the treatment of moderate to severe depression RJ DeRubeis, SD Hollon, JD Amsterdam, RC Shelton, PR Young, ... Archives of general psychiatry 62 (4), 409-416, 2005 | 1565 | 2005 |
| Prevention of relapse following cognitive therapy vs medications in moderate to severe depression SD Hollon, RJ DeRubeis, RC Shelton, JD Amsterdam, RM Salomon, ... Archives of general psychiatry 62 (4), 417-422, 2005 | 1276 | 2005 |
| A novel augmentation strategy for treating resistant major depression RC Shelton, GD Tollefson, M Tohen, S Stahl, KS Gannon, TG Jacobs, ... American Journal of Psychiatry 158 (1), 131-134, 2001 | 825 | 2001 |
| Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. MT Treadway, NA Bossaller, RC Shelton, DH Zald Journal of abnormal psychology 121 (3), 553, 2012 | 714 | 2012 |
| Effectiveness of St John's wort in major depression: a randomized controlled trial RC Shelton, MB Keller, A Gelenberg, DL Dunner, R Hirschfeld, ME Thase, ... Jama 285 (15), 1978-1986, 2001 | 645 | 2001 |
| Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial EJ Daly, JB Singh, M Fedgchin, K Cooper, P Lim, RC Shelton, ME Thase, ... JAMA psychiatry 75 (2), 139-148, 2018 | 569 | 2018 |
| Functional biomarkers of depression: diagnosis, treatment, and pathophysiology HD Schmidt, RC Shelton, RS Duman Neuropsychopharmacology 36 (12), 2375-2394, 2011 | 511 | 2011 |
| Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression RC Shelton, J Claiborne, M Sidoryk-Wegrzynowicz, R Reddy, M Aschner, ... Molecular psychiatry 16 (7), 751-762, 2011 | 499 | 2011 |
| A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression JB Singh, M Fedgchin, EJ Daly, P De Boer, K Cooper, P Lim, C Pinter, ... American Journal of Psychiatry 173 (8), 816-826, 2016 | 483 | 2016 |
| Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind … V Popova, EJ Daly, M Trivedi, K Cooper, R Lane, P Lim, C Mazzucco, ... American Journal of Psychiatry 176 (6), 428-438, 2019 | 462 | 2019 |
| Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study AJ Rush, MH Trivedi, JW Stewart, AA Nierenberg, M Fava, BT Kurian, ... American Journal of Psychiatry 168 (7), 689-701, 2011 | 437 | 2011 |
| Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. JC Fournier, RJ DeRubeis, RC Shelton, SD Hollon, JD Amsterdam, ... Journal of consulting and clinical psychology 77 (4), 775, 2009 | 423 | 2009 |
| Personality change during depression treatment: a placebo-controlled trial TZ Tang, RJ DeRubeis, SD Hollon, J Amsterdam, R Shelton, B Schalet Archives of general psychiatry 66 (12), 1322-1330, 2009 | 418 | 2009 |
| Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major … GI Papakostas, ME Thase, M Fava, JC Nelson, RC Shelton Biological psychiatry 62 (11), 1217-1227, 2007 | 413 | 2007 |
| Cognitive therapy and pharmacotherapy for depression. SD Hollon, RC Shelton, PT Loosen Journal of consulting and clinical psychology 59 (1), 88, 1991 | 412 | 1991 |
| Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial EJ Daly, MH Trivedi, A Janik, H Li, Y Zhang, X Li, R Lane, P Lim, AR Duca, ... JAMA psychiatry 76 (9), 893-903, 2019 | 393 | 2019 |
| Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features AJ Rush, M Zimmerman, SR Wisniewski, M Fava, SD Hollon, D Warden, ... Journal of affective disorders 87 (1), 43-55, 2005 | 368 | 2005 |
| l-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials GI Papakostas, RC Shelton, JM Zajecka, B Etemad, K Rickels, A Clain, ... American Journal of Psychiatry 169 (12), 1267-1274, 2012 | 331 | 2012 |
| Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. GI Papakostas, RC Shelton, J Smith, M Fava Journal of Clinical Psychiatry 68 (6), 826-831, 2007 | 317 | 2007 |
Steven HollonVanderbilt UniversityGeverifieerd e-mailadres voor vanderbilt.edu
